Journal article · 2018

A Methodology for Prioritizing Pediatric Pharmacokinetic Studies and Pharmacogenomic Implementation using Evidence from Patient Drug Safety Data

Andy Roger Eugene, Beata Eugene, Robert DiCenzo, Arthur F. Harralson

The FASEB Journal, 32(S1) · Published 1 April 2018 · DOI 10.1096/fasebj.2018.32.1_supplement.lb641

View at the publisherCite this paper

In brief

“A Methodology for Prioritizing Pediatric Pharmacokinetic Studies and Pharmacogenomic Implementation using Evidence from Patient Drug Safety Data” is a 2018 journal article by Andy Roger Eugene and 3 co-authors, published in The FASEB Journal. OpenAlex counts 0 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
Authors
4

Abstract

Introduction Physicians attempting to integrate pharmacogenomic testing into routine patient care have been limited due to insurance company reimbursements. However, hospitals committed to improving patient safety outcomes are integrating pharmacogenomic consultations from board‐certified pharmacologists and clinical pharmacists to provide personalized dosing via pharmacogenomic and pharmacometrics tools. Therefore we sought to identify and prioritize drug‐gene pairs… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Eugene, A. R., Eugene, B., DiCenzo, R., & Harralson, A. F. (2018). A Methodology for Prioritizing Pediatric Pharmacokinetic Studies and Pharmacogenomic Implementation using Evidence from Patient Drug Safety Data. The FASEB Journal, 32(S1). https://doi.org/10.1096/fasebj.2018.32.1_supplement.lb641

MLA 9

Eugene, Andy Roger, et al. “A Methodology for Prioritizing Pediatric Pharmacokinetic Studies and Pharmacogenomic Implementation using Evidence from Patient Drug Safety Data.” The FASEB Journal, vol. 32, no. S1, 2018. https://doi.org/10.1096/fasebj.2018.32.1_supplement.lb641.

Chicago

Eugene, Andy Roger, Beata Eugene, Robert DiCenzo, and Arthur F. Harralson. 2018. “A Methodology for Prioritizing Pediatric Pharmacokinetic Studies and Pharmacogenomic Implementation using Evidence from Patient Drug Safety Data.” The FASEB Journal 32 (S1). https://doi.org/10.1096/fasebj.2018.32.1_supplement.lb641.

Harvard

Eugene, A. R. et al. (2018) ‘A Methodology for Prioritizing Pediatric Pharmacokinetic Studies and Pharmacogenomic Implementation using Evidence from Patient Drug Safety Data’, The FASEB Journal, 32(S1). doi:10.1096/fasebj.2018.32.1_supplement.lb641.

IEEE

A. R. Eugene, B. Eugene, R. DiCenzo, and A. F. Harralson, “A Methodology for Prioritizing Pediatric Pharmacokinetic Studies and Pharmacogenomic Implementation using Evidence from Patient Drug Safety Data,” The FASEB Journal, vol. 32, no. S1, 2018, doi: 10.1096/fasebj.2018.32.1_supplement.lb641.

BibTeX

@article{eugene2018methodology,
  title     = {{A Methodology for Prioritizing Pediatric Pharmacokinetic Studies and Pharmacogenomic Implementation using Evidence from Patient Drug Safety Data}},
  author    = {Eugene, Andy Roger and Eugene, Beata and DiCenzo, Robert and Harralson, Arthur F.},
  journal   = {The FASEB Journal},
  year      = {2018},
  volume    = {32},
  number    = {S1},
  doi       = {10.1096/fasebj.2018.32.1_supplement.lb641},
  url       = {https://doi.org/10.1096/fasebj.2018.32.1_supplement.lb641}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pediatric pharmacokinetics
  • pharmacogenomics
  • adverse drug reactions
  • drug safety
  • FDA Adverse Event Reporting System
  • drug-gene associations
  • ondansetron
  • risperidone

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Eugene, A. R., Eugene, B., DiCenzo, R., & Harralson, A. F. (2018). A Methodology for Prioritizing Pediatric Pharmacokinetic Studies and Pharmacogenomic Implementation using Evidence from Patient Drug Safety Data. The FASEB Journal, 32(S1). https://doi.org/10.1096/fasebj.2018.32.1_supplement.lb641

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Andy Roger Eugene, Beata Eugene, Robert DiCenzo, Arthur F. Harralson.

What is the DOI of this paper?

10.1096/fasebj.2018.32.1_supplement.lb641, permanently at https://doi.org/10.1096/fasebj.2018.32.1_supplement.lb641. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.